Vimarsana
Biggest News Aggregation in the World

Page 6 - Opposition Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Opposition Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Opposition Division Today - Breaking & Trending Today

Investegate |NuCana plc Announcements | NuCana plc: Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's '190 Patent is Not Valid - Vimarsana News

Investegate |NuCana plc Announcements | NuCana plc: Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's '190 Patent is Not Valid

Investegate announcements from NuCana plc, Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid

NuCana plc: Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's '190 Patent is Not Valid - Vimarsana News

NuCana plc: Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's '190 Patent is Not Valid

Ruling Has No Impact on NuCana's Anti-Cancer ProTide PatentsMUNICH, Germany, March 24, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that, following a hearing on March 24, 2023, the Technical

HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE - Vimarsana News

HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today provides an update on a decision by the Opposition Division of the European...

Trademark Insight - January - Current trademark law decisions from Germany, Alicante and Luxembourg | Hogan Lovells - Vimarsana News

Trademark Insight - January - Current trademark law decisions from Germany, Alicante and Luxembourg | Hogan Lovells

Trademark Insight. With this format, we will be informing you at regular intervals about current trademark law decisions of German courts, the EUIPO and the European Union Courts. Each...

Estar Medical: The European Patent Office Revokes Two Regenlab PRP Patents - Vimarsana News

Estar Medical: The European Patent Office Revokes Two Regenlab PRP Patents

HOLON, Israel, Jan. 23, 2023 /PRNewswire/ -- Estar Medical® has been successful in revoking Regenlab's original patent for making platelet rich plasma (PRP) at the European Patent Office (EPO).